Related content

Integrating Perioperative Chemotherapy into the Treatment of Muscle-Invasive Bladder Cancer: Strategy Versus Reality

By Donat S. Machele  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 1, 2009-01 ,pp. : 40-47

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Gynecologic cancer outcomes in the elderly poor: A population-based study

By Doll Kemi M.   Meng Ke   Basch Ethan M.   Gehrig Paola A.   Brewster Wendy R.   Meyer Anne-Marie  

Cancer, Vol. 121, Iss. 20, 2015-10 ,pp. : 3591-3599

Blackwell Publishing

Access to resources Recommend Favorite

Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer

By Galsky Matthew D.   Pal Sumanta K.   Chowdhury Simon   Harshman Lauren C.   Crabb Simon J.   Wong Yu-Ning   Yu Evan Y.   Powles Thomas   Moshier Erin L.   Ladoire Sylvain   Hussain Syed A.   Agarwal Neeraj   Vaishampayan Ulka N.   Recine Federica   Berthold Dominik   Necchi Andrea   Theodore Christine   Milowsky Matthew I.   Bellmunt Joaquim   Rosenberg Jonathan E.   Galsky Matthew D.  

Cancer, Vol. 121, Iss. 15, 2015-08 ,pp. : 2586-2593

Blackwell Publishing

Access to resources Recommend Favorite

Investigational therapies for non-muscle invasive bladder cancer

By Smaldone Marc C   Casella Daniel P   Welchons Daniel R   Gingrich Jeffrey R  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 3, 2010-03 ,pp. : 371-383

Informa Healthcare

Access to resources Recommend Favorite

Population-based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 years

By  

Cancer, Vol. 121, Iss. 22, 2015-11 ,pp. : 4062-4070

Blackwell Publishing

Access to resources Recommend Favorite